BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.
Description
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Mateo, California, United States, North America